Chorionic Gonadotropin, Beta - Subunit (Quantitative), serum - Tumour Marker
Beta-HCG, HCG, HCG Tumour Quant
Equipment : Roche Cobas Pro e801
Method : The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.
Sandwich principle. Total duration of assay: 18 minutes.
▪ 1st incubation: 6 µL of sample, biotinylated monoclonal hCG‑specific antibodies, and a monoclonal hCG‑specific antibody labeled with a ruthenium complexa) react to form a sandwich complex.
▪ 2nd incubation: After addition of streptavidin-coated microparticles, the complex becomes bound to the solid phase via interaction of biotin and
streptavidin.
▪ The reaction mixture is aspirated into the measuring cell where the microparticles are magnetically captured onto the surface of the electrode. Unbound substances are then removed with ProCell II M. Application of a voltage to the electrode then induces chemiluminescent emission which is measured by a photomultiplier.
▪ Results are determined via a calibration curve which is instrument specific, generated by 2‑point calibration and a master curve provided via the cobas link.
Immunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotrophin (hCG) plus the B-subunit in human serum and plasma.
This assay is intended for use as an aid in:
- Oncology to serve in the management of patients with trophoblastic disease. This assay is useful in the detection and monitoring of hCG-producing tumor cells of either ovarian, placental or testicular origin.
Browse tests by laboratory
Customer Service
Toll Free: 1-855-381-3212
Local: 416-813-7200

